X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (56) 56
index medicus (41) 41
humans (37) 37
male (23) 23
cancer (22) 22
female (22) 22
aged (21) 21
chemotherapy (20) 20
middle aged (20) 20
adult (19) 19
lung cancer (19) 19
care and treatment (18) 18
lung neoplasms - drug therapy (15) 15
respiratory system (14) 14
aged, 80 and over (13) 13
lung cancer, non-small cell (13) 13
research (13) 13
therapy (13) 13
prognosis (12) 12
carcinoma, non-small-cell lung - drug therapy (11) 11
lung neoplasms - genetics (11) 11
lung neoplasms - pathology (10) 10
metastasis (10) 10
mutation (10) 10
neoplasm staging (10) 10
treatment outcome (10) 10
carcinoma, non-small-cell lung - pathology (9) 9
analysis (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
crizotinib (8) 8
medicine & public health (8) 8
neoplasms. tumors. oncology. including cancer and carcinogens (8) 8
patients (8) 8
adenocarcinoma (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
cancer therapies (7) 7
diagnosis (7) 7
hematology, oncology and palliative medicine (7) 7
immunology (7) 7
immunotherapy (7) 7
non-small cell lung cancer (7) 7
protein kinase inhibitors - therapeutic use (7) 7
retrospective studies (7) 7
survival (7) 7
alk (6) 6
cell lung-cancer (6) 6
gene (6) 6
genetic aspects (6) 6
immunohistochemistry (6) 6
medicine/public health, general (6) 6
melanoma (6) 6
radiotherapy (6) 6
solid tumors (6) 6
adenocarcinoma - genetics (5) 5
biomarkers (5) 5
double-blind (5) 5
expression (5) 5
head and neck cancer (5) 5
hospitals (5) 5
kinases (5) 5
management (5) 5
medicine (5) 5
molecular targeted therapy (5) 5
nsclc (5) 5
pulmonary/respiratory (5) 5
research paper (5) 5
src (5) 5
survival analysis (5) 5
switzerland (5) 5
tumors (5) 5
tyrosine (5) 5
tyrosine kinase inhibitor (5) 5
antineoplastic agents - pharmacology (4) 4
antineoplastic agents - therapeutic use (4) 4
biomarkers, tumor - genetics (4) 4
carcinoma (4) 4
combined modality therapy (4) 4
consensus (4) 4
drug therapy (4) 4
follow-up studies (4) 4
gene rearrangement (4) 4
human-papillomavirus (4) 4
inhibitor of differentiation protein 1 (4) 4
ipilimumab (4) 4
lung neoplasms - mortality (4) 4
medical prognosis (4) 4
medical research (4) 4
medicine, general & internal (4) 4
mutations (4) 4
nivolumab (4) 4
oncology, experimental (4) 4
open-label (4) 4
patterns of care (4) 4
phase-iii (4) 4
practice patterns (4) 4
prospective studies (4) 4
radiation-therapy (4) 4
research article (4) 4
respiratory tract diseases (4) 4
review (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 09/2016, Volume 11, Issue 9, pp. 1376 - 1378
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2014, Volume 3, Issue 6, pp. 379 - 381
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 05/2016, Volume 12, pp. 735 - 741
Rearrangements in ALK gene and EML4 gene were first described in 2007. This genomic aberration is found in about 2%-8% of non-small-cell lung cancer (NSCLC)... 
ALK | Crizotinib | Lung cancer | Ceritinib | Treatment outcome | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Analysis | Gene amplification | Chemotherapy | Lymphomas | Metastasis | Mutation | Kinases | Patients | Cancer therapies
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2013, Volume 3, p. 158
Lung cancer is the leading cause of cancer deaths worldwide. microRNAs (miRNAs) are a class of small non-coding RNA species that have been implicated in the... 
Therapy | microRNA | Biomarker | Prognosis | Diagnosis | Lung cancer | lung cancer | miRNA | diagnosis | biomarker | therapy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 9, pp. 992 - +
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21069 - e21069
Journal Article
Molecular and cellular therapies, ISSN 2052-8426, 2014, Volume 2, Issue 1, p. 7
MicroRNAs (miRNAs or miRs) are a family of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological... 
Research | Cell differentiation | Mediation | Oncology, Experimental | Stem cells | Cancer
Journal Article
BMC Medical Informatics and Decision Making, ISSN 1472-6947, 10/2018, Volume 18, Issue 1, pp. 89 - 18
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 03/2016, Volume 4, Issue 1, p. 13
Background: Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have been... 
Autoimmunity | Anti-tumor T cell response | Antibody | Autopsy | Immunotherapy | Ipilimumab | Nivolumab | Melanoma | Immune checkpoint inhibitors | INTERLEUKIN-2 | PD-1 BLOCKADE | IMMUNOLOGY | DOCETAXEL | TRANSPLANTATION | CELL LUNG-CANCER | ANTI-CTLA-4 | ONCOLOGY | SARCOIDOSIS | Development and progression | Care and treatment | Lung cancer, Non-small cell | Analysis
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S721 - S722
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S721 - S722
Journal Article
The Journal of pathology, ISSN 0022-3417, 08/2019
In non-small cell lung cancer (NSCLC) immune checkpoint inhibitors (ICIs) significantly improve overall survival (OS). Tumor mutational burden (TMB) has... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.